“…There is evidence for a genetic contribution alexithymia (Theorell, Lennartsson, Mosing, & Ullen, 2014), as well as for environmental causes. Alexithymia is associated with several health outcomes, such as depression (Li, Zhang, Guo, & Zhang, 2015), hypertension (Grabe et al, 2010;Jorgensen & Houston, 1986), sympathetic overactivity (Fukunishi, Sei, Morita, & Rahe, 1999), somatic complaints and symptoms (De Gucht & Heiser, 2003), as well as to lower quality of life (Mattila et al, 2010(Mattila et al, , 2009) and life satisfaction (even after controlling for physical health and depression) (Mattila, Poutanen, Koivisto, Salokangas, & Joukamaa, 2007). The most commonly used instrument for assessing alexithymia is the Toronto Alexithymia Scale (TAS-20) which consists of 20 questions (Bagby, Parker, & Taylor, 1994;Parker, Taylor, & Bagby, 2003).…”